Colonnade Closes its Third Insurance Premium Finance Transaction of 2024
Colonnade Advises Pathward Financial on the Sale of its Insurance Premium Finance Business to Honor Capital CLEARWATER, Fla., Nov. 7, 2024 /PRNewswire/ — Pathward Financial, Inc. (Nasdaq: CASH) announced that its wholly owned subsidiary Pathward®, N.A. (“Pathward”), an industry le
FirstEnergy Names Karen Sagot Vice President, Investor Relations, and Sean Davies Vice President, Continuous Improvement
Sagot brings two decades of finance and utility experience; Davies brings three decades of experience driving operational excellence and enterprise transformation AKRON, Ohio, Nov. 8, 2024 /PRNewswire/ — FirstEnergy Corp. (NYSE: FE) announced today that Karen Sagot has been named Vice Presiden
Duke Energy kicks off monthlong campaign providing more than $500,000 to help fight hunger in South Carolina
Funds will support more than 50 feeding programs as holidays approach and communities recover from Helene Efforts begin with Yam Jam, a volunteer event in Greenville that packages 50,000 pounds of sweet potatoes for the hungry this Thanksgiving GREENVILLE, S.C., Nov. 8, 2024 /PRNewswire/ — Eve
Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024
CRANBURY, N.J., Nov. 8, 2024 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2025 operating results on Thursday, November 14, 2024, before the open of the U.S. financial markets. Palatin will also conduct a conference call and live aud
HUYABIO Presents Positive Phase 2 Data on HBI-8000 and Nivolumab Combination for Advanced Melanoma
Data supporting the potential for innovative combinations like HBI-8000 and nivolumab to reshape the future of melanoma treatment will be presented at the Society for Immunotherapy of Cancer Annual Meeting SAN DIEGO, Nov. 8, 2024 /PRNewswire/ — HUYABIO International today announced it will p
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Allarity To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Allarity between May 17, 2022 and July 19, 2024 and would lik
Canadian Investment Regulatory Organization Trade Resumption – SOL
VANCOUVER, BC, Nov. 8, 2024 /CNW/ – Trading resumes in: Company: SOL Global Investments Corp. CSE Symbol: SOL All Issues: Yes Resumption (ET): 10:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are impl
GSA Releases Seafood Processing Standard Version 6.0
PORTSMOUTH, N.H., Nov. 7, 2024 /PRNewswire/ — Global Seafood Alliance (GSA) is pleased to announce the official release of the Seafood Processing Standard (SPS) version 6.0. Key features of the standard include a restructured modular framework built around core food safety requirements coverin
Celebrate the 250th Anniversary of the United States in 2026 with the Best of Canada & New England Cruise and Cruisetour Options from Princess
Sapphire Princess Sails First-Ever Season, Along with Return of Majestic Princess, Featuring Three Departure Ports FT. LAUDERDALE, Fla., Nov. 8, 2024 /PRNewswire/ — For travelers seeking to discover the beauty of the changing colors of the fall leaves, seaside villages and historic charm, Pri
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ”Healthy China”
SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed
